Chemo plus a local treatment for locally advanced pancreatic cancer
Part of Cancer clinical trials.
This study looks at how well combining standard chemo with a targeted local treatment works for people with locally advanced pancreatic cancer. It may help control the cancer in the area of origin and improve outcomes compared with chemo alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have biopsy-proven pancreatic ductal adenocarcinoma (pancreatic cancer confirmed by a tissue sample).
- Your cancer is “locally advanced,” meaning it has not spread to distant organs (no metastasis).
- Your cancer team believes you can safely receive combination chemotherapy.
- You are not pregnant.
- You do not have another active cancer at the same time (except some limited skin cancers or very early cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different chemotherapy combinations, each paired with immunotherapy and radiation, as the first treatment for locally advanced pancreatic cancer. It aims to see which combination works better.
This trial tests a combined treatment of chemotherapy followed by a precise type of radiation therapy (SBRT) for people with pancreatic cancer that cannot be surgically removed. It is designed for those who have not yet started treatment for locally advanced disease.
This trial is testing a new way to treat pancreatic cancer that has spread to nearby tissues but not to distant organs. It uses a tailored plan that may include chemotherapy and possibly surgery. The goal is to see if this personalized approach helps people live longer and better.
This trial studies a procedure called NanoKnife IRE for pancreatic cancer that cannot be removed surgically after standard chemotherapy or radiation. It uses electric pulses to destroy tumor cells and may be an option for patients who have completed other treatments.
This early study tests a combination of chemotherapy and a procedure called irreversible electroporation (IRE) for people with stage III pancreatic cancer. It may help shrink or control tumors, and also studies safety in this group.
This Phase 2 study looks at whether adding immunotherapy to a procedure called irreversible electroporation can help treat stage III pancreatic cancer. You might be eligible if you have measurable tumors and can safely undergo the procedure.
Hear when a new Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.